Medipattern’s B-CADTM Version 2 Shown To Increase Diagnostic Accuracy By 44% In Lesions Less Than 1 Cm In Size

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is ple

More: continued here

Filed under: Breast Cancer on February 13th, 2008